Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Further consolidation ahead for Nifty? Here's today's outlook and top picks
Ajit Mishra of Religare Broking has recommended buying the shares of Fortis Healthcare, RBL Bank, and Eternal today
India's healthcare transformed in 12 years under PM Modi: Report
India's healthcare sector has seen a major transformation over the last 12 years. Health insurance coverage has expanded significantly. Maternal and child healthcare has improved. Medical infrastructure has seen a substantial increase. The government has focused on making healthcare accessible and affordable for all citizens.
Carlyle Eyes India IPO For Healthcare RCM Provider After Recent Acquisition
Carlyle has started discussions with investment banks for a possible India IPO of its healthcare billing venture.
Up 44%+ in June, these healthcare stocks are rallying once again - Investing.com India
Up 44%+ in June, these healthcare stocks are rallying once againInvesting.com India
Margin play: Why Supertails is doubling down on the lucrative pet healthcare market
With medical services yielding double the margins of retail, the startup is expanding its clinic and pharmacy footprint to anchor itself at the centre of India's formalizing pet economy.
Pharma in her DNA, Wockhardt scion ready for deep dive in the US
Zahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacterial infections and is a significant bet for the company. Zaynich's US approval marks a major breakthrough after decades without new antibiotics. Zahabiya is focused on hospital penetration, physician advocacy, and demonstrating economic value to healthcare systems.
Bernstein backs Zydus, Lupin and Sun Pharma on innovation shift
Nandan Kulkarni, Director–India Healthcare & Senior Research Analyst at Bernstein, sees strong opportunities in CDMOs, specialty therapies, biosimilars and licensing deals. While favouring Zydus, Lupin and Sun Pharma, he remains cautious on Biocon and Mankind Pharma, and argues that India's shift from generics to innovation could drive the next phase of growth for the pharma industry.
Indian cancer patients battle shortage of key drugs as platinum costs surge
Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues are causing shortages. This forces patients to search extensively for medication. Some drugmakers have reduced production. The situation puts immense pressure on the healthcare system and patients seeking treatment.
Bernstein bets on Indian healthcare, sees these three stocks as key beneficiaries
According to Bernstein, valuations across the Indian biopharma sector have re-rated significantly, with the Nifty Pharma index trading slightly above its 10-year average multiple of 30.5 times its one-year forward earnings. However, it noted that its preferred stocks continue to trade below their long-term average valuations.
Top stocks to buy today: Anand James of Geojit bets on theses 3 shares
Anand James, chief market strategist at Geojit Investments, is bullish on the shares of Jindal Steel, SJS Enterprises, and Fortis Healthcare today
Five Stocks To Buy: ICICI Bank, Bharti Airtel, Fortis Healthcare And More | June 09, 2026
Top picks include private sector lenders ICICI Bank and Federal Bank, telecom giant Bharti Airtel, and hospital chain Fortis Healthcare.
Truist cuts Omega Healthcare stock price target on valuation By Investing.com - Investing.com India
Truist cuts Omega Healthcare stock price target on valuation By Investing.comInvesting.com India